Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trial
Authors:
- Scott E. JordanSJScott E. Jordan
- Antonio González-MartinAGAntonio González-Martin
- Robert MorlockRMRobert Morlock
- Lena HubigLHLena Hubig
- Kan YonemoriKYKan Yonemori
- Lauriane EberstLELauriane Eberst
- Michal ZikanMZMichal Zikan
- Hee Seung KimHKHee Seung Kim
- Susana BanerjeeSBSusana Banerjee
- Fernanda DamianFDFernanda Damian
- Vanda SalutariVSVanda Salutari
- Stéphanie HenrySHStéphanie Henry
Open Access
- 11 August 2026
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (11)
Abstract
No abstract availableFunding Information
- Pfizer
- Seagen
- Genmab
This publication has 23 references indexed in Scilit:
- 722P Long-term patient-reported outcomes (PROs) with atezolizumab (atezo) + bevacizumab (bev) and chemotherapy (CT) for metastatic, persistent or recurrent cervical cancer (R/M CC): BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030) randomised phase III trialAnnals of Oncology, 2024
- Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer typesEuropean Journal of Cancer, 2023
- Recurrent or primary metastatic cervical cancer: current and future treatmentsESMO Open, 2022
- Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathyToxicology and Applied Pharmacology, 2021
- Factors associated with poor quality of life among cervical cancer survivors: Implications for clinical care and clinical trialsGynecologic Oncology, 2014
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- The European Organization for Research and Treatment of Cancer (EORTC) Quality‐of‐Life questionnaire cervical cancer moduleCancer, 2006
- Assessing and interpreting treatment effects in longitudinal clinical trials with missing dataBiological Psychiatry, 2003
- The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30Quality of Life Research, 1996
- The EORTC Core Quality of Life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapyEuropean Journal of Cancer, 1995